Summary:

 

The event featured several esteemed speakers who shared their knowledge and expertise on different aspects of gastrointestinal cancers and immunotherapy. Prof. Rachel Riechelmann from AC Camargo Cancer Center Brazil served as the chair and moderator for the event.

Prof. Yelena Janjingian from Memorial Sloan Kettering Cancer Center in New York, USA, started the event with a presentation on mechanisms of immune checkpoint blockade in solid tumors. She provided valuable insights into the topic, which was followed by a Q&A session.

Dr. Elena Elimova from Princess Margaret Hospital in Toronto, Canada, then presented on immunotherapy in esophageal cancers. Her presentation shed light on the latest developments and advancements in this field. The Q&A session that followed allowed attendees to further delve into the topic.

Dr. Guillermo Mendez from Fundación Favaloro in Buenos Aires, Argentina, discussed predictive markers for immune checkpoint inhibitors. He presented the current knowledge and research in this area, addressing the importance of these markers in guiding treatment decisions. The subsequent Q&A session provided attendees with an opportunity to clarify any doubts or seek further information.

Prof. Yelena Janjingian returned to the stage to give a presentation on immunotherapy in gastric cancer. Her insights and expertise in this field were highly valuable for the attendees. The Q&A session that followed allowed for meaningful discussions and the exchange of ideas.

The event concluded with a challenging cases presentation and discussion, led by Dr. Renata Dalpino and Dr. Tiago Felismino. This segment provided real-world scenarios where attendees could apply the knowledge gained during the event. It offered an interactive and practical approach to further understanding the topics discussed.